It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Astrocytes play important roles in neurological disorders such as stroke, injury, and neurodegeneration. Most knowledge on astrocyte biology is based on studies of mouse models and the similarities and differences between human and mouse astrocytes are insufficiently characterized, presenting a barrier in translational research. Based on analyses of acutely purified astrocytes, serum-free cultures of primary astrocytes, and xenografted chimeric mice, we find extensive conservation in astrocytic gene expression between human and mouse samples. However, the genes involved in defense response and metabolism show species-specific differences. Human astrocytes exhibit greater susceptibility to oxidative stress than mouse astrocytes, due to differences in mitochondrial physiology and detoxification pathways. In addition, we find that mouse but not human astrocytes activate a molecular program for neural repair under hypoxia, whereas human but not mouse astrocytes activate the antigen presentation pathway under inflammatory conditions. Here, we show species-dependent properties of astrocytes, which can be informative for improving translation from mouse models to humans.
Astrocytes are important players in brain development, homeostasis, and disease. Here, the authors compare the transcriptional profiles of human and mouse astrocytes. They report species-specific susceptibility to oxidative stress and response to hypoxic and inflammatory conditions.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Pan, Lin 1 ; Pembroke, William G 2 ; Rexach, Jessica E 2 ; Godoy, Marlesa I 1
; Condro, Michael C 1 ; Alvarado, Alvaro G 1 ; Mineli, Harteni 1 ; Yen-Wei, Chen 3 ; Stiles Linsey 4
; Chen, Angela Y 5
; Wanner, Ina B 6 ; Yang, Xia 7 ; Goldman, Steven A 8 ; Geschwind, Daniel H 9
; Kornblum, Harley I 10 ; Zhang, Ye 11
1 David Geffen School of Medicine at the University of California, Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
2 David Geffen School of Medicine at the University of California, Department of Neurology, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
3 University of California, Department of Integrative Biology and Physiology, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
4 David Geffen School of Medicine at the University of California, Department of Endocrinology, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
5 University of California, Department of Obstetrics and Gynecology, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
6 David Geffen School of Medicine at the University of California, Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); Intellectual and Developmental Disabilities Research Center at UCLA, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
7 University of California, Department of Integrative Biology and Physiology, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); Institute for Quantitative and Computational Biosciences at UCLA, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); Brain Research Institute at UCLA, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); Molecular Biology Institute at UCLA, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
8 University of Rochester Medical Center, Center for Translational Neuromedicine and Department of Neurology, Rochester, USA (GRID:grid.412750.5) (ISNI:0000 0004 1936 9166); University of Copenhagen Faculty of Health and Medical Sciences, Center for Translational Neuromedicine, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X)
9 David Geffen School of Medicine at the University of California, Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); David Geffen School of Medicine at the University of California, Department of Neurology, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); David Geffen School of Medicine at the University of California, Department of Human Genetics, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
10 David Geffen School of Medicine at the University of California, Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); Intellectual and Developmental Disabilities Research Center at UCLA, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); Molecular Biology Institute at UCLA, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); David Geffen School of Medicine at the University of California, Department of Pediatrics, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
11 David Geffen School of Medicine at the University of California, Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); Intellectual and Developmental Disabilities Research Center at UCLA, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); Brain Research Institute at UCLA, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); Molecular Biology Institute at UCLA, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)




